Skip to contentSkip to footer
      employer cover photo
      employer logo
      employer logo

      MYR Pharmaceuticals

      Is this your company?

      Find the right fit for you - faster

      Get tailored insights about working at MYR Pharmaceuticals in one quick step.

      MYR Pharmaceuticals Snapshot

      Be the first to review this company

      Biotech & PharmaceuticalsIndustry
      Description MYR Pharmaceuticals is a German biotechnology company focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company’s lead compound bulevirtide (Myrcludex) is a first-in-class entry inhibitor for treatment of chronic HVB and HDV and is currently in a Phase 3 study in the indication of chronic HDV. As an inhibitor of the bile acid transporter NTCP, bulevirtide (Mycludex) also opens up new possibilities for the treatment of a variety of inflammatory and metabolic diseases.

      Life at MYR Pharmaceuticals

      Related searches: MYR Pharmaceuticals jobs | MYR Pharmaceuticals salaries | MYR Pharmaceuticals benefits | MYR Pharmaceuticals interviews
      CompaniesAbout MYR Pharmaceuticals

      Glassdoor gives you an inside look at what it's like to work at MYR Pharmaceuticals, including salaries, reviews, office photos, and more. This is the MYR Pharmaceuticals company profile. All content is posted anonymously by employees working at MYR Pharmaceuticals.